ADMA logo

ADMA Biologics (ADMA) Working Capital

ADMA Annual Working Capital

$207.21 M
-$23.93 M-10.35%

31 December 2023

ADMA Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Quarterly Working Capital

$273.30 M
+$13.79 M+5.31%

30 September 2024

ADMA Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-10.3%+17.9%
3 y3 years+54.9%+18.2%
5 y5 years+493.6%+18.2%

ADMA Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-10.3%+16.2%at high+53.2%
5 y5-year-10.3%+188.6%at high+280.7%
alltimeall time-10.3%>+9999.0%at high>+9999.0%

ADMA Biologics Working Capital History

DateAnnualQuarterly
Sept 2024
-
$273.30 M(+5.3%)
June 2024
-
$259.51 M(+16.2%)
Mar 2024
-
$223.33 M(+7.8%)
Dec 2023
$207.21 M(-10.4%)
$207.21 M(-10.6%)
Sept 2023
-
$231.86 M(+3.4%)
June 2023
-
$224.29 M(-1.3%)
Mar 2023
-
$227.36 M(-1.6%)
Dec 2022
$231.13 M(+29.6%)
$231.13 M(+28.7%)
Sept 2022
-
$179.65 M(-7.7%)
June 2022
-
$194.70 M(-6.5%)
Mar 2022
-
$208.23 M(+16.8%)
Dec 2021
$178.35 M(+33.3%)
$178.35 M(+25.2%)
Sept 2021
-
$142.45 M(-7.0%)
June 2021
-
$153.17 M(-1.9%)
Mar 2021
-
$156.07 M(+16.7%)
Dec 2020
$133.79 M(+86.4%)
$133.79 M(+8.7%)
Sept 2020
-
$123.07 M(-5.4%)
June 2020
-
$130.11 M(-14.2%)
Mar 2020
-
$151.58 M(+111.1%)
Dec 2019
$71.79 M(+105.7%)
$71.79 M(-12.6%)
Sept 2019
-
$82.17 M(-12.4%)
June 2019
-
$93.76 M(+212.6%)
Mar 2019
-
$30.00 M(-14.1%)
Dec 2018
$34.90 M(-34.0%)
$34.90 M(-33.7%)
Sept 2018
-
$52.61 M(-21.1%)
June 2018
-
$66.71 M(+80.4%)
Mar 2018
-
$36.98 M(-30.1%)
Dec 2017
$52.90 M
$52.90 M(+192.2%)
Sept 2017
-
$18.11 M(-36.8%)
DateAnnualQuarterly
June 2017
-
$28.63 M(+950.4%)
Mar 2017
-
$2.73 M(-73.9%)
Dec 2016
$10.43 M(-38.9%)
$10.43 M(-35.4%)
Sept 2016
-
$16.15 M(-33.8%)
June 2016
-
$24.41 M(+86.8%)
Mar 2016
-
$13.07 M(-23.5%)
Dec 2015
$17.07 M(-14.2%)
$17.07 M(-18.5%)
Sept 2015
-
$20.94 M(-12.5%)
June 2015
-
$23.93 M(-12.0%)
Mar 2015
-
$27.20 M(+36.7%)
Dec 2014
$19.89 M(-27.4%)
$19.89 M(+7.8%)
Sept 2014
-
$18.45 M(-18.7%)
June 2014
-
$22.70 M(-14.3%)
Mar 2014
-
$26.48 M(-3.3%)
Dec 2013
$27.39 M(+125.8%)
$27.39 M(+492.1%)
Sept 2013
-
$4.63 M(-35.2%)
June 2013
-
$7.14 M(-30.0%)
Mar 2013
-
$10.20 M(-15.9%)
Dec 2012
$12.13 M(<-9900.0%)
$12.13 M(+14.7%)
Sept 2012
-
$10.58 M(-22.3%)
June 2012
-
$13.61 M(-8.1%)
Mar 2012
-
$14.82 M(>+9900.0%)
Dec 2011
-
$2800.00(-171.8%)
Sept 2011
-
-$3900.00(+200.0%)
June 2011
-$1300.00(+225.0%)
-$1300.00(-112.5%)
Mar 2011
-
$10.40 K(-711.8%)
Dec 2010
-
-$1700.00(+325.0%)
June 2010
-
-$400.00
June 2010
-$400.00
-

FAQ

  • What is ADMA Biologics annual working capital?
  • What is the all time high annual working capital for ADMA Biologics?
  • What is ADMA Biologics annual working capital year-on-year change?
  • What is ADMA Biologics quarterly working capital?
  • What is the all time high quarterly working capital for ADMA Biologics?
  • What is ADMA Biologics quarterly working capital year-on-year change?

What is ADMA Biologics annual working capital?

The current annual working capital of ADMA is $207.21 M

What is the all time high annual working capital for ADMA Biologics?

ADMA Biologics all-time high annual working capital is $231.13 M

What is ADMA Biologics annual working capital year-on-year change?

Over the past year, ADMA annual working capital has changed by -$23.93 M (-10.35%)

What is ADMA Biologics quarterly working capital?

The current quarterly working capital of ADMA is $273.30 M

What is the all time high quarterly working capital for ADMA Biologics?

ADMA Biologics all-time high quarterly working capital is $273.30 M

What is ADMA Biologics quarterly working capital year-on-year change?

Over the past year, ADMA quarterly working capital has changed by +$41.44 M (+17.87%)